Global Brain Disease Modalities And Software Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06254022

Publication Date:

June 20, 2025

Pages:

132

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Brain Disease Modalities And Software market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Brain Disease Modalities And Software is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Brain Disease Modalities And Software is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Brain Disease Modalities And Software is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Brain Disease Modalities And Software players cover Quantib, Brainomix, General Electric, Imaging Biometrics, United Imaging Healthcare Co, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淏rain Disease Modalities And Software Industry Forecast鈥� looks at past sales and reviews total world Brain Disease Modalities And Software sales in 2024, providing a comprehensive analysis by region and market sector of projected Brain Disease Modalities And Software sales for 2025 through 2031. With Brain Disease Modalities And Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Brain Disease Modalities And Software industry.
This Insight Report provides a comprehensive analysis of the global Brain Disease Modalities And Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Brain Disease Modalities And Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Brain Disease Modalities And Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Brain Disease Modalities And Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Brain Disease Modalities And Software.
This report presents a comprehensive overview, market shares, and growth opportunities of Brain Disease Modalities And Software market by product type, application, key players and key regions and countries.
Segmentation by Type:
Brain Imaging Modalities
Brain Analysis Software
Segmentation by Application:
Adults
Pediatrics and Infants
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Quantib
Brainomix
General Electric
Imaging Biometrics
United Imaging Healthcare Co
Siemens
Healthineers AG
Koninklijke Philips N.V.
Canon
Vuno
Aspect Imaging
IXICO
QMENTA
I. Analysis
Fujifilm Holdings
Other Prominent Players

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Brain Disease Modalities And Software Market Size (2020-2031)
2.1.2 Brain Disease Modalities And Software Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Brain Disease Modalities And Software by Country/Region (2020, 2024 & 2031)
2.2 Brain Disease Modalities And Software Segment by Type
2.2.1 Brain Imaging Modalities
2.2.2 Brain Analysis Software
2.3 Brain Disease Modalities And Software Market Size by Type
2.3.1 Brain Disease Modalities And Software Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Brain Disease Modalities And Software Market Size Market Share by Type (2020-2025)
2.4 Brain Disease Modalities And Software Segment by Application
2.4.1 Adults
2.4.2 Pediatrics and Infants
2.5 Brain Disease Modalities And Software Market Size by Application
2.5.1 Brain Disease Modalities And Software Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Brain Disease Modalities And Software Market Size Market Share by Application (2020-2025)
3 Brain Disease Modalities And Software Market Size by Player
3.1 Brain Disease Modalities And Software Market Size Market Share by Player
3.1.1 Global Brain Disease Modalities And Software Revenue by Player (2020-2025)
3.1.2 Global Brain Disease Modalities And Software Revenue Market Share by Player (2020-2025)
3.2 Global Brain Disease Modalities And Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Brain Disease Modalities And Software by Region
4.1 Brain Disease Modalities And Software Market Size by Region (2020-2025)
4.2 Global Brain Disease Modalities And Software Annual Revenue by Country/Region (2020-2025)
4.3 Americas Brain Disease Modalities And Software Market Size Growth (2020-2025)
4.4 APAC Brain Disease Modalities And Software Market Size Growth (2020-2025)
4.5 Europe Brain Disease Modalities And Software Market Size Growth (2020-2025)
4.6 Middle East & Africa Brain Disease Modalities And Software Market Size Growth (2020-2025)
5 Americas
5.1 Americas Brain Disease Modalities And Software Market Size by Country (2020-2025)
5.2 Americas Brain Disease Modalities And Software Market Size by Type (2020-2025)
5.3 Americas Brain Disease Modalities And Software Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Brain Disease Modalities And Software Market Size by Region (2020-2025)
6.2 APAC Brain Disease Modalities And Software Market Size by Type (2020-2025)
6.3 APAC Brain Disease Modalities And Software Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Brain Disease Modalities And Software Market Size by Country (2020-2025)
7.2 Europe Brain Disease Modalities And Software Market Size by Type (2020-2025)
7.3 Europe Brain Disease Modalities And Software Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Brain Disease Modalities And Software by Region (2020-2025)
8.2 Middle East & Africa Brain Disease Modalities And Software Market Size by Type (2020-2025)
8.3 Middle East & Africa Brain Disease Modalities And Software Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Brain Disease Modalities And Software Market Forecast
10.1 Global Brain Disease Modalities And Software Forecast by Region (2026-2031)
10.1.1 Global Brain Disease Modalities And Software Forecast by Region (2026-2031)
10.1.2 Americas Brain Disease Modalities And Software Forecast
10.1.3 APAC Brain Disease Modalities And Software Forecast
10.1.4 Europe Brain Disease Modalities And Software Forecast
10.1.5 Middle East & Africa Brain Disease Modalities And Software Forecast
10.2 Americas Brain Disease Modalities And Software Forecast by Country (2026-2031)
10.2.1 United States Market Brain Disease Modalities And Software Forecast
10.2.2 Canada Market Brain Disease Modalities And Software Forecast
10.2.3 Mexico Market Brain Disease Modalities And Software Forecast
10.2.4 Brazil Market Brain Disease Modalities And Software Forecast
10.3 APAC Brain Disease Modalities And Software Forecast by Region (2026-2031)
10.3.1 China Brain Disease Modalities And Software Market Forecast
10.3.2 Japan Market Brain Disease Modalities And Software Forecast
10.3.3 Korea Market Brain Disease Modalities And Software Forecast
10.3.4 Southeast Asia Market Brain Disease Modalities And Software Forecast
10.3.5 India Market Brain Disease Modalities And Software Forecast
10.3.6 Australia Market Brain Disease Modalities And Software Forecast
10.4 Europe Brain Disease Modalities And Software Forecast by Country (2026-2031)
10.4.1 Germany Market Brain Disease Modalities And Software Forecast
10.4.2 France Market Brain Disease Modalities And Software Forecast
10.4.3 UK Market Brain Disease Modalities And Software Forecast
10.4.4 Italy Market Brain Disease Modalities And Software Forecast
10.4.5 Russia Market Brain Disease Modalities And Software Forecast
10.5 Middle East & Africa Brain Disease Modalities And Software Forecast by Region (2026-2031)
10.5.1 Egypt Market Brain Disease Modalities And Software Forecast
10.5.2 South Africa Market Brain Disease Modalities And Software Forecast
10.5.3 Israel Market Brain Disease Modalities And Software Forecast
10.5.4 Turkey Market Brain Disease Modalities And Software Forecast
10.6 Global Brain Disease Modalities And Software Forecast by Type (2026-2031)
10.7 Global Brain Disease Modalities And Software Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Brain Disease Modalities And Software Forecast
11 Key Players Analysis
11.1 Quantib
11.1.1 Quantib Company Information
11.1.2 Quantib Brain Disease Modalities And Software Product Offered
11.1.3 Quantib Brain Disease Modalities And Software Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Quantib Main Business Overview
11.1.5 Quantib Latest Developments
11.2 Brainomix
11.2.1 Brainomix Company Information
11.2.2 Brainomix Brain Disease Modalities And Software Product Offered
11.2.3 Brainomix Brain Disease Modalities And Software Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Brainomix Main Business Overview
11.2.5 Brainomix Latest Developments
11.3 General Electric
11.3.1 General Electric Company Information
11.3.2 General Electric Brain Disease Modalities And Software Product Offered
11.3.3 General Electric Brain Disease Modalities And Software Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 General Electric Main Business Overview
11.3.5 General Electric Latest Developments
11.4 Imaging Biometrics
11.4.1 Imaging Biometrics Company Information
11.4.2 Imaging Biometrics Brain Disease Modalities And Software Product Offered
11.4.3 Imaging Biometrics Brain Disease Modalities And Software Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Imaging Biometrics Main Business Overview
11.4.5 Imaging Biometrics Latest Developments
11.5 United Imaging Healthcare Co
11.5.1 United Imaging Healthcare Co Company Information
11.5.2 United Imaging Healthcare Co Brain Disease Modalities And Software Product Offered
11.5.3 United Imaging Healthcare Co Brain Disease Modalities And Software Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 United Imaging Healthcare Co Main Business Overview
11.5.5 United Imaging Healthcare Co Latest Developments
11.6 Siemens
11.6.1 Siemens Company Information
11.6.2 Siemens Brain Disease Modalities And Software Product Offered
11.6.3 Siemens Brain Disease Modalities And Software Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Siemens Main Business Overview
11.6.5 Siemens Latest Developments
11.7 Healthineers AG
11.7.1 Healthineers AG Company Information
11.7.2 Healthineers AG Brain Disease Modalities And Software Product Offered
11.7.3 Healthineers AG Brain Disease Modalities And Software Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Healthineers AG Main Business Overview
11.7.5 Healthineers AG Latest Developments
11.8 Koninklijke Philips N.V.
11.8.1 Koninklijke Philips N.V. Company Information
11.8.2 Koninklijke Philips N.V. Brain Disease Modalities And Software Product Offered
11.8.3 Koninklijke Philips N.V. Brain Disease Modalities And Software Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Koninklijke Philips N.V. Main Business Overview
11.8.5 Koninklijke Philips N.V. Latest Developments
11.9 Canon
11.9.1 Canon Company Information
11.9.2 Canon Brain Disease Modalities And Software Product Offered
11.9.3 Canon Brain Disease Modalities And Software Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Canon Main Business Overview
11.9.5 Canon Latest Developments
11.10 Vuno
11.10.1 Vuno Company Information
11.10.2 Vuno Brain Disease Modalities And Software Product Offered
11.10.3 Vuno Brain Disease Modalities And Software Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Vuno Main Business Overview
11.10.5 Vuno Latest Developments
11.11 Aspect Imaging
11.11.1 Aspect Imaging Company Information
11.11.2 Aspect Imaging Brain Disease Modalities And Software Product Offered
11.11.3 Aspect Imaging Brain Disease Modalities And Software Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Aspect Imaging Main Business Overview
11.11.5 Aspect Imaging Latest Developments
11.12 IXICO
11.12.1 IXICO Company Information
11.12.2 IXICO Brain Disease Modalities And Software Product Offered
11.12.3 IXICO Brain Disease Modalities And Software Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 IXICO Main Business Overview
11.12.5 IXICO Latest Developments
11.13 QMENTA
11.13.1 QMENTA Company Information
11.13.2 QMENTA Brain Disease Modalities And Software Product Offered
11.13.3 QMENTA Brain Disease Modalities And Software Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 QMENTA Main Business Overview
11.13.5 QMENTA Latest Developments
11.14 I. Analysis
11.14.1 I. Analysis Company Information
11.14.2 I. Analysis Brain Disease Modalities And Software Product Offered
11.14.3 I. Analysis Brain Disease Modalities And Software Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 I. Analysis Main Business Overview
11.14.5 I. Analysis Latest Developments
11.15 Fujifilm Holdings
11.15.1 Fujifilm Holdings Company Information
11.15.2 Fujifilm Holdings Brain Disease Modalities And Software Product Offered
11.15.3 Fujifilm Holdings Brain Disease Modalities And Software Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Fujifilm Holdings Main Business Overview
11.15.5 Fujifilm Holdings Latest Developments
11.16 Other Prominent Players
11.16.1 Other Prominent Players Company Information
11.16.2 Other Prominent Players Brain Disease Modalities And Software Product Offered
11.16.3 Other Prominent Players Brain Disease Modalities And Software Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Other Prominent Players Main Business Overview
11.16.5 Other Prominent Players Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂